文献速递甲状腺核医学核素与放射性配体治疗

放射性碘治疗

Radioiodine Therapy.
PubMed 文献 · Semin Nucl Med · 2016-11-01

本文综述儿童恶性甲状腺疾病中放射性碘治疗的适应证、实际操作与争议。儿童131I治疗几乎仅用于分化型甲状腺癌(DTC),因生物学行为、体重相关剂量及适应证与成人不同而需特殊考量。在专家核医学医师正确应用下,131I治疗是高效且耐受良好的肿瘤治疗手段。

要点

  • 儿童131I治疗几乎仅用于分化型甲状腺癌(DTC)。
  • 儿童DTC因生物学行为、较低体重所致剂量差异及良好预后与潜在长期不良反应,需特殊考量适应证。
  • 专家核医学医师正确应用时,131I治疗是高效且耐受良好的儿童DTC治疗手段。

核心结论

  • 在专家核医学医师正确应用下,131I治疗是高效的肿瘤治疗,已被证明是儿童DTC管理中有效且耐受良好的方法。

研究设计与样本

  • 本文为综述,旨在概述儿童恶性甲状腺肿瘤131I治疗的适应证、实际操作与争议。

主要发现

  • 儿童131I治疗几乎仅用于DTC,因儿童DTC生物学行为与成人不同、患者体重较低导致剂量差异、多数患者预后良好且预期寿命长存在潜在不良反应,适应证需特殊考量。

关键数值与推荐

  • 儿童DTC因生物学行为与成人不同、体重较低导致剂量差异、多数预后良好且长期生存者存在潜在不良反应,需特殊考量131I治疗适应证。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radioiodine therapy for benign and malignant thyroid disease rose at the birth of nuclear medicine. Since then, this procedure has been performed countless of times in adult and in pediatric patients alike, and has contributed to a normalization of life expectancy in all but I-131 refractory differentiated thyroid cancer (DTC) cases. As 131I therapy in children is almost exclusively given for DTC, this review of radioiodine therapy in children focuses on patients with malignant thyroid disease. The aim of the present review is to provide an overview of the indications, practical execution, and controversies surrounding 131I therapy for malignant tumors in pediatric patients. In pediatric patients, special considerations apply for 131I therapy for DTC because of differences in biological behavior to adult DTC, differences in dosaging caused by patients' lower bodyweight, and differences in the indication for 131I therapy because of the inherently good prognosis in most patients and potential adverse effects in patients with a long life expectancy. However, if applied correctly, 131I therapy in the hands of expert nuclear medicine physicians is a highly effective oncologic therapy, which has proven to represent an effective and well-tolerated procedure in the management of pediatric patients with DTC.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Luster M, Pfestroff A, Hänscheid H, et al. Radioiodine Therapy. Semin Nucl Med. 2016. PMID: 28237001. doi:10.1053/j.semnuclmed.2016.10.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。